EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
|
1992年
/
47卷
/
01期
关键词:
HRT;
CALCITONIN;
BONE LOSS;
D O I:
10.1016/0028-2243(92)90214-J
中图分类号:
R71 [妇产科学];
学科分类号:
100211 ;
摘要:
A total of 104 postmenopausal women were randomly assigned to different therapeutic regimens: (a) calcitonin, (b) estrogen/progestogen (HRT) plus calcitonin, (c) estrogen/progestogen (HRT), (d) and the control group. The bone mass of the lumbar vertebrae of all patients was assessed with a dual beam photon absorptiometer (Norland GD 153). The 73 patients who completed the 1-yr study showed that postmenopausal bone loss could be prevented by either estrogen/progestogen (HRT) or calcitonin. In addition, the combination of hormonel replacement therapy and calcitonin not only prevented postmenopausal bone loss but resulted in a significant 10% gain in bone mass (P < 0.001).
机构:
Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA
Univ Calif San Diego, Dept Pediat, La Jolla, CA USAUniv Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA
Dothard, M. I.
Allard, S. M.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA
Univ Calif San Diego, Dept Pediat, La Jolla, CA USAUniv Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA
Allard, S. M.
Gilbert, J. A.
论文数: 0引用数: 0
h-index: 0
机构:
Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA
Univ Calif San Diego, Dept Pediat, La Jolla, CA USA
Univ Calif San Diego, Dept Pediat, La Jolla, CA 92037 USAUniv Calif San Diego, Biomed Sci Grad Program, La Jolla, CA USA